
zzso active zzso therapy zzso is associated with loss of subcutaneous fat zzso presumably due to zzso toxicity of zzso reverse zzso zzso In zzso zzso abrogates zzso zzso toxicity in zzso 

A total of 20 patients with zzso zzso were zzso to receive either a dietary zzso supplement zzso g three times a day for 10 consecutive zzso or zzso for 3 zzso Body composition was measured using dual energy X-ray zzso magnetic resonance imaging and zzso zzso Data are mean zzso standard error of zzso 

The mean increases in limb fat zzso zzso 140 versus 230 zzso zzso zzso P zzso zzso zzso fat (210 zzso 80 versus zzso zzso 70 zzso P zzso zzso and total body fat zzso zzso 240 versus 240 zzso 520 zzso P zzso zzso were significantly greater in the zzso than in the zzso zzso Within the zzso group, the changes from baseline to 3 months were statistically significant in total limb fat zzso zzso zzso zzso fat zzso zzso zzso and total body fat zzso zzso zzso The proportion of limb fat to total fat increased from zzso to zzso zzso zzso zzso in the zzso zzso Liver fat content and lean body mass remained unchanged in both zzso zzso zzso zzso decreased in the zzso and increased in the zzso group, whereas zzso serum insulin zzso did not zzso zzso supplementation was well tolerated and the zzso effect of zzso was not zzso 

zzso supplementation significantly and predominantly increased subcutaneous fat mass in zzso zzso patients during unchanged zzso 

